English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [1823]
News [2734]
Articles [202]
Editorials [1]
Conferences [136]
elearning [13]
New insights on genetic damage of some chemotherapies could guide future treatments with less harmful side effects
New insights on genetic damage of some chemotherapies could guide future treatments with less harmful side effects
Antibody-cancer drug combo shows promise against aggressive lymphoma
Antibody-cancer drug combo shows promise against aggressive lymphoma
Bioengineered tumour model offers new tool in fight against peritoneal cancers
Bioengineered tumour model offers new tool in fight against peritoneal cancers
Precision oncology Organ Chip platform accurately and actionably predicts chemotherapy responses of patients suffering from oesophageal adenocarcinoma
Precision oncology Organ Chip platform accurately and actionably predicts chemotherapy responses of patients...
FDA approves tafasitamab-cxix for relapsed or refractory follicular lymphoma
FDA approves tafasitamab-cxix for relapsed or refractory follicular lymphoma
Cracking carboplatin resistance: Forward genetics identifies Hn1l/Jpt2 as a novel player in ovarian cancer’s escape from platinum therapy
Cracking carboplatin resistance: Forward genetics identifies Hn1l/Jpt2 as a novel player in ovarian cancer’s...
Perioperative toripalimab and chemotherapy in resectable non-small cell lung cancer: Another weapon in the armamentarium
Perioperative toripalimab and chemotherapy in resectable non-small cell lung cancer: Another weapon in the...
Scientists uncover clues behind drug resistance in bowel cancer
Scientists uncover clues behind drug resistance in bowel cancer
Fixed-duration acalabrutinib-based regimens approved in EU for patients with chronic lymphocytic leukaemia in the 1st-line setting
Fixed-duration acalabrutinib-based regimens approved in EU for patients with chronic lymphocytic leukaemia in the...
Pancreatic cancer vaccines eliminate disease in preclinical trials
Pancreatic cancer vaccines eliminate disease in preclinical trials
<12345...274>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top